xCures and Imaging Biometrics are collaborating on an Expanded Access Protocol (EAP) providing compassionate use of gallium maltolate for participants with relapsed/refractory histologic or molecular glioblastoma who have exhausted standard-of-care therapies. Additional information can be found at the links below.
- Oral GaM – Musella Foundation (short video)
- Oral GaM – Musella Foundation (long version)
- Clinicaltrials.gov (NCT06404034)
If you or your doctor believes you, or someone for whom you are their Legally Authorized Representative, may be eligible to enroll, please register here. Registration takes about 5 minutes to complete.
Once your registration is complete, the xCures team will coordinate enrollment in the EAP and/or offer alternative treatment assistance as appropriate. We will work directly with your treating team to ensure the proper regulatory work has been completed and the order for gallium maltolate has been processed.
Please note that this program has costs. Once your registration is complete, please contact Linda Herman at eap@imagingbiometrics.com or by phone at 262-439-8252 for information on payment next steps and inquiries regarding financial assistance for this EAP.
Please feel free to contact the xCures team at expandedaccess@xcures.com with any questions about this process.
